ADHD is one of the most commonly diagnosed mental disorders in children, it is neither preventable nor cured. ADHD is often referred to as Attention Deficit Disorder.
It is observed that boys are most affected with ADHD as compared to girls. As per the NCBI, ADHD affects up to 1 in 20 children in the USA. Among the seven major markets the US accounted for about 28% of the total ADHD prevalent cases in 2017.
Difficulty in keeping their attention and concentration on tasks, forget or lose necessary things, difficulty in organising an activity, distraction by noise and unrelated thoughts, loseing track of daily activities are some of the key Inattentive symptoms of ADHD in childrens.
Similarly, fidgeting and squirming, talking excessively, Impulsive decision making, constant physical movement and touching objects are some of the key Hyperactivity and impulsivity symptoms of ADHD.
Several pharma players at the global level such as Aevi Genomic Medicine, Amarantus BioScience, NLS Pharma, Supernus Pharmaceuticals, Genentech, Otsuka Pharmaceutical, and RespireRx Pharmaceuticals are involved in the therapeutic development of ADHD.
For more details visit: https://www.delveinsight.com/blog/signs-and-symptoms-of-adhd/